Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03602443 · ClinicalTrials.gov registry record · NA
Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke
A NA study of Chronic Stroke, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03602443: Completed NA study of Chronic Stroke, sponsored by University of Missouri-Columbia.
NCT03602443 is a NA study of Chronic Stroke that has completed, run by University of Missouri-Columbia. The registered enrollment target is 5 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03602443, a NA study of Chronic Stroke, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate feasibility (acceptability, subject recruitment/retention, willingness to be randomized, and adherence rates) of delivering the Lee Silverman Voice Treatment®-BIG (LSVT®BIG) intervention with individuals with chronic stroke. Evaluate preliminary effect of the LSVT®BIG intervention on motor function and occupational performance with individuals with chronic stroke.
Primary Outcome
For each study participant, an percentage of clinic visits and home exercises completed will be calculated. Rates will be averaged within groups.
Conditions Studied
Interventions
- BEHAVIORAL Waitlist Control
- BEHAVIORAL LSVT®BIG Intervention
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-08-06 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03602443 record still lists
NCT03602443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Waitlist Control is the first listed.
NCT03602443 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03602443 about?
NCT03602443 is a clinical study titled "Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke". Evaluate feasibility (acceptability, subject recruitment/retention, willingness to be randomized, and adherence rates) of delivering the Lee Silverman Voice Treatment®-BIG (LSVT®BIG) intervention with individuals with chronic stroke. Evaluate preliminary effect of the LSVT®BIG intervention on motor ...
What is the current status of trial NCT03602443?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-08-06. Estimated completion is 2019-12-31.
What conditions does trial NCT03602443 study?
This clinical trial studies the following conditions: Chronic Stroke.
What interventions are being tested in trial NCT03602443?
The interventions under investigation include: Waitlist Control (BEHAVIORAL), LSVT®BIG Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03602443?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03602443 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03602443's enrollment target sits among peer trials
5 20th of 20 the lowest of 20 other Chronic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
Effect of NMES on Balance and Fall Risk in Chronic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Paired Vagus Nerve Stimulation Mechanisms
RECRUITING · NA
-
Home-based FES Training in People With Chronic Stroke
RECRUITING · NA
-
Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI